These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 25755609)
1. Risk factors for hepatocellular carcinoma in India. Kar P J Clin Exp Hepatol; 2014 Aug; 4(Suppl 3):S34-42. PubMed ID: 25755609 [TBL] [Abstract][Full Text] [Related]
2. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. Sarin SK; Thakur V; Guptan RC; Saigal S; Malhotra V; Thyagarajan SP; Das BC J Gastroenterol Hepatol; 2001 Jun; 16(6):666-73. PubMed ID: 11422620 [TBL] [Abstract][Full Text] [Related]
3. Incidence of hepatocellular carcinoma in a community-based Taiwanese population without chronic HBV/HCV infection. Wu HC; Jeng WJ; Pan MH; Hsieh YC; Lu SN; Chen CJ; Yang HI JHEP Rep; 2022 Feb; 4(2):100410. PubMed ID: 35079699 [TBL] [Abstract][Full Text] [Related]
4. Aflatoxin B Chu YJ; Yang HI; Wu HC; Lee MH; Liu J; Wang LY; Lu SN; Jen CL; You SL; Santella RM; Chen CJ Eur J Cancer; 2018 May; 94():37-46. PubMed ID: 29533866 [TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies. Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001 [TBL] [Abstract][Full Text] [Related]
6. Etiological and molecular profile of hepatocellular cancer from India. Asim M; Sarma MP; Kar P Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429 [TBL] [Abstract][Full Text] [Related]
7. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India. Anitha S; Raghunadharao D; Waliyar F; Sudini H; Parveen M; Rao R; Kumar PL Mutat Res Genet Toxicol Environ Mutagen; 2014 May; 766():23-8. PubMed ID: 24657665 [TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan. Chen DS Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606 [TBL] [Abstract][Full Text] [Related]
9. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma. Cohen D; Ghosh S; Shimakawa Y; Ramou N; Garcia PS; Dubois A; Guillot C; Kakwata-Nkor Deluce N; Tilloy V; Durand G; Voegele C; Ndow G; d'Alessandro U; Brochier-Armanet C; Alain S; Le Calvez-Kelm F; Hall J; Zoulim F; Mendy M; Thursz M; Lemoine M; Chemin I JHEP Rep; 2020 Oct; 2(5):100144. PubMed ID: 32904132 [TBL] [Abstract][Full Text] [Related]
11. The epidemiology and prevention of hepatocellular carcinoma. Monto A; Wright TL Semin Oncol; 2001 Oct; 28(5):441-9. PubMed ID: 11685737 [TBL] [Abstract][Full Text] [Related]
12. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease. Lin BZ; Lin TJ; Lin CL; Liao LY; Chang TA; Lu BJ; Chen KY J Chin Med Assoc; 2021 Jun; 84(6):606-613. PubMed ID: 33871391 [TBL] [Abstract][Full Text] [Related]
13. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Kew MC Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277 [TBL] [Abstract][Full Text] [Related]
16. Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review. Alavian SM; Haghbin H Hepat Mon; 2016 Mar; 16(3):e35106. PubMed ID: 27226803 [TBL] [Abstract][Full Text] [Related]
17. Epidemiological and etiological variations in hepatocellular carcinoma. Sagnelli E; Macera M; Russo A; Coppola N; Sagnelli C Infection; 2020 Feb; 48(1):7-17. PubMed ID: 31347138 [TBL] [Abstract][Full Text] [Related]
18. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Anwar WA; Khaled HM; Amra HA; El-Nezami H; Loffredo CA Mutat Res; 2008; 659(1-2):176-84. PubMed ID: 18346933 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology of digestive tract cancers in India. III. Liver. Dhir V; Mohandas KM Indian J Gastroenterol; 1998; 17(3):100-3. PubMed ID: 9695391 [TBL] [Abstract][Full Text] [Related]
20. Microsomal Epoxide Hydrolase Polymorphisms and Haplotypes as Determinants of Hepatitis B Virusand Hepatitis C Virus-related Liver Disease in Indian Population. Rahat B; Kiran M; Saxena R; Chawla YK; Sharma RR; Kaur J J Clin Exp Hepatol; 2012 Jun; 2(2):104-11. PubMed ID: 25755418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]